← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2008Last known activity
Aug 31, 2023
Timeline
1840s
- Jan 1, 1847
Hospital Juarez de Mexico— Founded
Drugs by trial phase (20 distinct, 12 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Brain Diseases
- Coronavirus Infections
- Depression
- Depressive Disorder
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Edema
- Fatty Liver
- Hepatic Encephalopathy
- Irritable Bowel Syndrome
- Macular Edema
- Metabolic Syndrome
- Non-alcoholic Fatty Liver Disease
- Obesity
- Obesity, Morbid
- Retinal Diseases
- Severe Acute Respiratory Syndrome
- Syndrome
- Weight Loss
Recent trials (30)
- NCT06009744Lead sponsorN/AAug 31, 2023
- NCT06009744Overall official - principal investigatorN/AAug 31, 2023
- NCT06009744Reponsible party - principal investigatorN/AAug 31, 2023
- NCT04626089Overall official - principal investigatorPhase 2Nov 30, 2020
- NCT04645745CollaboratorN/AJun 15, 2019
- NCT04164394Lead sponsorN/AMay 13, 2019
- NCT04164394Reponsible party - principal investigatorN/AMay 13, 2019
- NCT04164394Study directorN/AMay 13, 2019
- NCT04145856Reponsible party - principal investigatorPhase 4Sep 3, 2018
- NCT04145856Study directorPhase 4Sep 3, 2018
- NCT04145856Lead sponsorPhase 4Sep 3, 2018
- NCT03849729Overall official - principal investigatorPhase 4Mar 1, 2018
- NCT03849729Reponsible party - principal investigatorPhase 4Mar 1, 2018
- NCT03849729Lead sponsorPhase 4Mar 1, 2018
- NCT04000711CollaboratorN/AJul 1, 2015
Details
- Founded
- MX Jan 1, 1847
- Last known activity
- Aug 31, 2023